» Articles » PMID: 32640539

Otoprotective Effect of 2,3,4',5-Tetrahydroxystilbene-2--β-d-Glucoside on Gentamicin-Induced Apoptosis in Mouse Cochlear UB/OC-2 Cells

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Jul 10
PMID 32640539
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive levels of reactive oxygen species (ROS) lead to mitochondrial damage and apoptotic cell death in gentamicin-induced ototoxicity. 2,3,4',5-Tetrahydroxystilbene-2--β-d-glucoside (THSG), a bioactive constituent, isolated from Thunb., exhibits numerous biological benefits in treating aging-related diseases by suppressing oxidative damage. However, its protective effect on gentamicin-induced ototoxicity remains unexplored. Therefore, here, we aimed to investigate the otoprotective effect of THSG on gentamicin-induced apoptosis in mouse cochlear UB/OC-2 cells. We evaluated the effect of gentamicin and THSG on the ROS level, superoxide dismutase (SOD) activity, mitochondrial membrane potential, nuclear condensation, and lactate dehydrogenase (LDH) release, and the expression of apoptosis-related proteins was assessed to understand the molecular mechanisms underlying its preventive effects. The findings demonstrated that gentamicin increased ROS generation, LDH release, and promoted apoptotic cell death in UB/OC-2 cells. However, THSG treatment reversed these effects by suppressing ROS production and downregulating the mitochondrial-dependent apoptotic pathway. Additionally, it increased the SOD activity, decreased the expression of apoptosis-related proteins, alleviated the levels of the apoptotic cells, and impaired cytotoxicity. To the best of our knowledge, this is the first study to demonstrate that THSG could be a potential therapeutic option to attenuate gentamicin-induced ototoxicity.

Citing Articles

2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside ameliorates bleomycin-induced pulmonary fibrosis regulating pro-fibrotic signaling pathways.

Huang T, Chen C, Chen L, Lan Y, Huang T, Choo K Front Pharmacol. 2022; 13:997100.

PMID: 36267283 PMC: 9577370. DOI: 10.3389/fphar.2022.997100.


In vitro and in vivo models: What have we learnt about inner ear regeneration and treatment for hearing loss?.

Lee M, Waldhaus J Mol Cell Neurosci. 2022; 120:103736.

PMID: 35577314 PMC: 9551661. DOI: 10.1016/j.mcn.2022.103736.


2,3,4',5‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside ameliorates gentamicin‑induced ototoxicity by modulating autophagy via Sesn2/AMPK/mTOR signaling.

Wen Y, Lin H, Lin J, Tseng G, Hwang C, Lin C Int J Mol Med. 2022; 49(5).

PMID: 35348190 PMC: 8989425. DOI: 10.3892/ijmm.2022.5127.


A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside.

Wang C, Dai S, Gong L, Fu K, Ma C, Liu Y Front Pharmacol. 2022; 12:791214.

PMID: 35069206 PMC: 8769241. DOI: 10.3389/fphar.2021.791214.

References
1.
Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, Alnemri E . Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91(4):479-89. DOI: 10.1016/s0092-8674(00)80434-1. View

2.
Clerici W, Hensley K, DiMartino D, Butterfield D . Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res. 1996; 98(1-2):116-24. DOI: 10.1016/0378-5955(96)00075-5. View

3.
Arslan E, Orzan E, Santarelli R . Global problem of drug-induced hearing loss. Ann N Y Acad Sci. 2000; 884:1-14. DOI: 10.1111/j.1749-6632.1999.tb00277.x. View

4.
Zhou M, Sun G, Zhang L, Zhang G, Yang Q, Yin H . STK33 alleviates gentamicin-induced ototoxicity in cochlear hair cells and House Ear Institute-Organ of Corti 1 cells. J Cell Mol Med. 2018; 22(11):5286-5299. PMC: 6201369. DOI: 10.1111/jcmm.13792. View

5.
Ojano-Dirain C, Antonelli P . Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone. Laryngoscope. 2012; 122(11):2543-8. DOI: 10.1002/lary.23593. View